Published in Heart Rhythm on September 16, 2008
Late perforation of Durata ICD lead--a case report. Indian Heart J (2014) 0.81
Implantable cardioverter-defibrillator lead complication: when is an outbreak out of bounds? Heart Rhythm (2008) 0.75
Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review. J Arrhythm (2016) 0.75
Delayed cardiac perforation of the Durata implantable cardioverter-defibrillator lead more than 1 year after implantation. HeartRhythm Case Rep (2016) 0.75
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol (2013) 5.67
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol (2013) 4.07
Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med (2013) 3.76
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol (2012) 3.36
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator. Heart Rhythm (2007) 3.23
Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol (2009) 3.16
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation (2010) 2.93
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ Res (2012) 2.74
Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol (2013) 2.65
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res (2005) 2.52
Materials for multifunctional balloon catheters with capabilities in cardiac electrophysiological mapping and ablation therapy. Nat Mater (2011) 2.51
Importance of catheter contact force during irrigated radiofrequency ablation: evaluation in a porcine ex vivo model using a force-sensing catheter. J Cardiovasc Electrophysiol (2010) 2.47
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res (2002) 2.29
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol (2002) 1.87
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. Heart Rhythm (2006) 1.87
Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke (2011) 1.82
Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol (2005) 1.78
Towards regenerative therapy for cardiac disease. Lancet (2012) 1.75
Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol (2008) 1.75
Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm (2006) 1.75
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm (2010) 1.66
Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT). J Cardiovasc Electrophysiol (2010) 1.65
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Role of implantable cardioverter-defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol (2008) 1.63
Intracardiac echocardiographic imaging of the left atrial appendage. Heart Rhythm (2005) 1.63
The permanency of pulmonary vein isolation using a balloon cryoablation catheter. J Cardiovasc Electrophysiol (2010) 1.62
Use of intracardiac echocardiography to guide implantation of a left atrial appendage occlusion device (PLAATO). Heart Rhythm (2007) 1.61
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail (2014) 1.60
Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol (2014) 1.59
Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol (2002) 1.58
Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol (2009) 1.57
Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies. Arch Intern Med (2004) 1.55
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm (2012) 1.54
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol (2009) 1.54
Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2006) 1.54
Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome. Europace (2010) 1.53
Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. J Am Coll Cardiol (2004) 1.53
The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm (2009) 1.52
Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50
Variability of coronary venous anatomy in patients undergoing cardiac resynchronization therapy: a high-speed rotational venography study. Heart Rhythm (2007) 1.50
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol (2009) 1.48
Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome. Eur Heart J (2007) 1.48
Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction. J Cardiovasc Electrophysiol (2003) 1.47
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46
The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol (2005) 1.46
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol (2005) 1.45
Electronic sensor and actuator webs for large-area complex geometry cardiac mapping and therapy. Proc Natl Acad Sci U S A (2012) 1.45
Effectiveness of a real-time clinical decision support system for computerized physician order entry of plasma orders. Transfusion (2013) 1.45
A novel pacing method to suppress repolarization alternans in vivo: implications for arrhythmia prevention. Heart Rhythm (2012) 1.44
Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol (2003) 1.43
Multiple ICD discharges associated with lead fracture without triggering of high impedance alert. Pacing Clin Electrophysiol (2009) 1.42